Graham Cooper barrels in as Geron CFO
This article was originally published in Scrip
Geron Corporation has appointed Graham Cooper executive vice-president of finance and business development and chief financial officer. From 2006 to 2011, Mr Cooper served as senior vice-president, CFO and treasurer of Orexigen Therapeutics, where he was instrumental in growing the company from a venture-backed start-up into a sizeable public company.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.